3 October 2014 Text size Home About Fermion APIs CMO Contacts Orion Corporation News from Fermion Fermion connected chemists at the 6th Nordic Process Chemistry Forum In total 67 chemists and chemical engineers came together to listen to 14... (6 June 2014) Fermion's Hanko Plant maintains the status "acceptable" by the FDA Fermion passed successfully the FDA 2014 Inspection with three minor 483... (20 March 2014) Fermion's Oulu Plant maintains the status “acceptable" by the FDA Fermion passed successfully the FDA 2013 Inspection with no 483 remarks and... (10 February 2014) Fermion's Area for Potent Compounds now Operational Fermion, a specialist in manufacturing anticancer products since its inception... (12 June 2012) FERMION Manufacturer of Active Pharmaceutical Ingredients (API) for both generic and proprietary drug products since 1970. Contract manufacturing services for APIs including oncology and highly potent compounds. Meet us at: CPhI Worldwide Pharma Expo, Paris, 7 - 9 October, 2014, Booth 6K59 QUICK LINKS List of API's MSDS Responsible care Standard Sales and Delivery Conditions Fermion Oy, Koivu-Mankkaan tie 6A, FI-02200 Espoo, Finland TEL. +358 10 4261 FAX: +358 9 452 1764 e-mail: fermionSales@orion.fi Contacts

29 October 2014 Text size Home About Fermion APIs CMO Contacts Orion Corporation Oncology/High Potency Compounds CMO Business Processes Confidentiality Manufacturing of dosage forms Home / CMO Print CMO Fermion has two plants in Finland. Hanko Plant is intended for large-volume APIs, whereas the Oulu Plant is dedicated to large and small-scale highly potent API´s (up to OEL class V compounds, < 1.0 µg/m3). Fermion's main competence is developing innovative APIs from Phase I onwards to commercialization. It has a wide range of expertise in manufacturing anticancer products, especially pteridine and fully synthetic camptothecin derivatives. Today, as the wholly-owned subsidiary of Orion Corporation, we offer Contract Manufacturing Services to our worldwide customer base. To date, Fermion has developed and manufactured the API for more than 10 innovative pharmaceutical products that have been commercialized worldwide or are currently awaiting regulatory approval. Fermion focuses on further developing products in P I or later. WE OFFER: - FEE FOR SERVICE (FTE BASED) - CONTRACT MANUFACTURING OF INTERMEDIATES AND APIS - PRODUCT VALIDATION AND COMMERCIAL VOLUMES - REGULATORY SERVICES - ANALYTICAL DEVELOPMENT AND VALIDATION Updated 27 May 2014 Contact: fermionCMO@orion.fi Fermion Oy, Koivu-Mankkaan tie 6A, FI-02200 Espoo, Finland TEL. +358 10 4261 FAX: +358 9 452 1764 e-mail: fermionSales@orion.fi Contacts